Clinical Trial Update: Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of tenofovir disoproxil fumarate 300 mg in Chinese adults with chronic hepatitis B; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2013-08-16